Ridden by Jack Tudor, the pair raced prominently in the four-runner field and a superb jump at the last allowed Egbert to ...

The U.S. raid in Caracas and the capture of Nicolás Maduro marks more than a dramatic episode in foreign intervention. It ...

The new year is only a few days old, President Trump is clearly in business mode, once again turning global power and the way ...

The new year is only a few days old, President Trump is clearly in business mode, once again turning global power and the way ...

Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional ...

Alan Dudman delivers his Big Race Verdict on Saturday's Lanzarote Hurdle at Kempton and predicts a one two three with a tip ...

Mobile email design demands precision, strategy, and a deep understanding of device constraints. This article compiles 16 ...

Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and ...

Liverpool Enter Growing Race for Brighton Midfielder Carlos BalebaAccording to a report by Caught Offside, Liverpool are ...

HUHUTECH International Group Inc. ( ($HUHU) ) just unveiled an update. HUHUTECH International Group Inc., a Cayman Islands–incorporated company ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Eisai And Nuvation Bio Enter Into Exclusive Licensing Agreement For Taletrectinib In Europe And Additional Countries Outside The U.S., China And Japan. Eisai and Nuvation Bio Enter into Exclusive ...